Skip to main content

Notice

We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: https://rda-login.wicketcloud.com/users/confirmation. Visitors may encounter functionality issues with group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool on the bottom right corner of each page. Thank you for your understanding and support as we work through all issues as quickly as possible. Stay updated about upcoming features and functionalities: https://www.rd-alliance.org/rda-web-platform-upcoming-features-and-functionalities/

Who We Are
What We Do
What We Work On
Get Involved
Events
RDA Groups
News & Media

New vaccine tested

  • Creator
    Discussion
  • March 25, 2020 at 10:08 pm #105050

    Caterina Tomulescu
    Member

    Dear all, 
    thank you for this group! 
    Caterina Tomulescu representing the National Institute for Chemical-Pharmaceutical Research&Development from Bucharest, Romania.
    I just want to share you some information regarding the Romania’s vaccine, which is currently tested in laborator. 
    Regards, 
    Be safe, Caterina
    Design of an Epitope-Based Synthetic Long Peptide Vaccine to Counteract the Novel China Coronavirus (2019-nCoV)
    |
    |
    |
    | | |
    |
    |
    |
    | |
    Design of an Epitope-Based Synthetic Long Peptide Vaccine to Counteract the Novel China Coronavirus (2019-nCoV)
    In this report, we demonstrate that it is possible to design epitope-based peptide vaccine candidates to counteract the novel China coronavirus (2019-nCoV) by using an approach similar to the one used in cancer neoantigen vaccination therapy. We iden
    | |
    |
    |
    Trimis din Yahoo Mail pe Android

  • Creator
    Discussion

Log in to reply.